Methyl N-[1-[(2S)-2-[5-[13-[2-[(2S)-1-[2-(dimethylamino)-2-phenylacetyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),6,8(16),11(15),12-pentaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
C45H52N8O6 — CID 139302334
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl N-[1-[(2S)-2-[5-[13-[2-[(2S)-1-[2-(dimethylamino)-2-phenylacetyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),6,8(16),11(15),12-pentaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
Methyl N-[1-[(2S)-2-[5-[13-[2-[(2S)-1-[2-(dimethylamino)-2-phenylacetyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),6,8(16),11(15),12-pentaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate (PubChem CID 139302334) has the molecular formula C45H52N8O6 and a molecular weight of 800.96 g/mol. Its IUPAC name is methyl N-[1-[(2S)-2-[5-[13-[2-[(2S)-1-[2-(dimethylamino)-2-phenylacetyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),6,8(16),11(15),12-pentaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate.
Molecular Properties
| Compound Name | Methyl N-[1-[(2S)-2-[5-[13-[2-[(2S)-1-[2-(dimethylamino)-2-phenylacetyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),6,8(16),11(15),12-pentaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate |
|---|---|
| PubChem CID | 139302334 |
| Molecular Formula | C45H52N8O6 |
| Molecular Weight | 800.96 g/mol |
| Exact Mass | 800.40 |
| IUPAC Name | methyl N-[1-[(2S)-2-[5-[13-[2-[(2S)-1-[2-(dimethylamino)-2-phenylacetyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),6,8(16),11(15),12-pentaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate |
| SMILES | COC(=O)NC(C(=O)N1CCC[C@H]1c1ncc(C2=CC3=C4c5c(cc(-c6cnc([C@@H]7CCCN7C(=O)C(c7ccccc7)N(C)C)[nH]6)cc5OCC4C2)CO3)[nH]1)C(C)C |
| InChI | InChI=1S/C45H52N8O6/c1-25(2)39(50-45(56)57-5)43(54)52-15-9-13-33(52)41-46-21-31(48-41)27-17-29-23-59-36-20-28(18-30-24-58-35(19-27)37(29)38(30)36)32-22-47-42(49-32)34-14-10-16-53(34)44(55)40(51(3)4)26-11-7-6-8-12-26/h6-8,11-12,18-22,25,29,33-34,39-40H,9-10,13-17,23-24H2,1-5H3,(H,46,48)(H,47,49)(H,50,56)/t29?,33-,34-,39?,40?/m0/s1 |
| InChIKey | PIKZWUHVTFGZEX-YKVTTWBJSA-N |
| XLogP | 6.55 |
| TPSA | 158.01 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 59 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 800.96 |
| LogP ≤ 5 | 6.55 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139302334 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.